A company, SUNRISE, is seeking initial approval in South Korea for a new drug offering a treatment option for brain health in Asia.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company, SUNRISE, is seeking initial approval in South Korea for a new drug offering a treatment option for brain health in Asia.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Drug approval targets the South Korean market, overseen by the Ministry of Food and Drug Safety.Sub-event
SUNRISE is pursuing initial drug approval in South Korea for a new brain health treatment.1 source